Home › Trial NCT02749526
Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial
- Trial IDNCT02749526
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorThe First Affiliated Hospital with Nanjing Medical University
- Enrollment70
- Start date2016-04
- ConditionsEsophageal
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.